Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MS Vision provides independent mass spectrometry service and advanced instrument upgrades to support large molecule analysis in biopharma. Their NativeQE solution enables high-resolution native mass spectrometry of intact proteins and complex biologics on the Thermo QExactive platform. They serve customers across pharma, biopharma, food control labs, academia, and government throughout Europe.
No clinical results as they do not develop therapeutics.
Known for expertise in high-mass/native ESI modifications enabling top-down protein characterization.
Customers include major pharmaceutical/biopharmaceutical companies as well as academic/government labs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MS Vision.